The second pre-event in the lead-up to IJET-25 in Tokyo next June will be co-hosted by JATPHARMA and KAT on Saturday, November 30 in Osaka. The JAT/SWET Kansai bonenkai will follow the same evening.
We look forward to you joining us!
Increasing Globalization of Clinical Trials and the Role of CROs:
How Professional Translators Can Meet the Challenges of the Changing Environment
Clinical trials in Japan have made remarkable advances, one of which is their increasing internationalization. Global clinical trials now account for more than 20 percent of those conducted in Japan. The endeavors of both industry and the Pharmaceuticals and Medical Devices Agency have borne fruit, with steady resolution of the drug lag issue (the delay in approving drugs for marketing in Japan). As key players in the contract development of pharmaceuticals and medical devices, contract research organizations (CROs) will not prosper unless they embrace this wave of internationalization. Addressing the needs of global clients and dealing with English-laden documents are pressing issues. CMIC is meeting the challenge of internationalization to cope with this changing environment, but a number of concerns remain. Translation professionals can help address those concerns.
How will the environment change in the future? How can professional translators cope with these coming changes? In my presentation, I will discuss expected customer needs from the standpoint of CROs, which work cooperatively on a routine basis with diverse clientele.
Presenter: Atsushi Tanase, Corporate Officer and General Manager, Consulting Division, CMIC Co., Ltd.
Born in Nagoya in 1957. Entered the Development Division of Fujisawa Pharmaceutical (now Astellas Pharma Inc.) in 1983. Involved in global development of the company’s pharmaceutical products, with six years based overseas in the United States and Germany. Became leader of product development at AstraZeneca K. K. (Osaka) in 2005. Joined CMIC Co., Ltd. in December 2012.
In his current role at CMIC, Atsushi Tanase uses his 30 years of experience in pharmaceutical development to consult with clients on development strategy and regulatory affairs for new drugs, as well as leading the company’s Medical Writing Department.
■Seminar (*in Japanese)
Time: 14:00–17:00 Saturday, November 30, 2013 (Doors open: 13:30)
Venue: TKP Osaka Umeda Business Center
Conference Room 9A
Cost: JAT members 2,500 JPY, Non-members 3,500 JPY
Advance registration is necessary for both members and non-members.
Click here for registration
JAT and SWET Kansai will hold a bonenkai-style networking dinner after the Pre-event. Details TBA.